Viewing Study NCT00138593


Ignite Creation Date: 2025-12-25 @ 1:17 AM
Ignite Modification Date: 2025-12-25 @ 11:26 PM
Study NCT ID: NCT00138593
Status: COMPLETED
Last Update Posted: 2017-03-01
First Post: 2005-08-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module